| Disease | hyperthyroidism |
| Phenotype | C0022658|kidney disease |
| Sentences | 1 |
| PubMedID- 22305461 | Cin is effective in clinical setting and it has been approved for the treatment of secondary hyperthyroidism in patients with chronic kidney disease placed on dialysis [3], and for the treatment of elevated calcium levels in patients with parathyroid carcinoma [4]. |
Page: 1